Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mrx-2843 (2 trials)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 1)
Neoplastic Processes (Phase 1)
Pathologic Processes (Phase 1)
Trials (2 total)
Trial APIs (1 total)